Suppliers / Icure Pharmaceutical

Icure Pharmaceutical

South Korea Updated 9 July 2026

Icure Pharmaceutical is a finished-dose manufacturer based in South Korea. It appears in 8 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), UZPHARM (UZ) and EEC_EAEU.

0
active US DMFs
0
valid CEPs
0
registered plants
8
filings across 3 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 5 None
UZPHARM (UZ) 2 None
EEC_EAEU 1 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Icure Pharmaceutical

Does Icure Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Icure Pharmaceutical. It does have 8 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Icure Pharmaceutical file?
Filings are on record with NPRA (MY), UZPHARM (UZ) and EEC (Eurasian Economic Union), 8 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Icure Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Binex Co.,ltd also in South Korea Celltrion Pharm also in South Korea Dongbang Future Tech & Life Co, Ltd (1731) also in South Korea High Tech Pharm also in South Korea Korea United Pharm also in South Korea

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability